The Transfusion 2024 team has been actively engaged in a range of projects aimed at enhancing patient safety and supporting our scientific and clinical workforce. As Transfusion 2024 transitions into Transfusion Transformation, we remain committed to implementing findings from the Infected Blood Inquiry, working closely with stakeholders, including patients and the public, to deliver key quality improvements. For further information, please feel free to contact any member of the team.
Healthcare professionals and other NBTC stakeholders may wish to note an update from Jehovah’s Witnesses regarding individual decisions on the acceptance and donation of major blood components.